Organon & Co. NYSE:OGN

Organon & stock price today

$9.28
-5.78
-38.38%
Financial Health
0
1
2
3
4
5
6
7
8
9

Organon & stock price monthly change

-29.30%
month

Organon & stock price quarterly change

-29.30%
quarter

Organon & stock price yearly change

+4.88%
year

Organon & key metrics

Market Cap
3.71B
Enterprise value
11.86B
P/E
2.98
EV/Sales
1.85
EV/EBITDA
7.03
Price/Sales
0.60
Price/Book
7.86
PEG ratio
0.14
EPS
4.11
Revenue
6.34B
EBITDA
1.46B
Income
1.04B
Revenue Q/Q
5.46%
Revenue Y/Y
3.28%
Profit margin
20.3%
Oper. margin
23.44%
Gross margin
58.26%
EBIT margin
23.44%
EBITDA margin
23.08%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Organon & stock price history

Organon & stock forecast

Organon & financial statements

Organon & Co. (NYSE:OGN): Profit margin
Jun 2023 1.60B 242M 15.05%
Sep 2023 1.51B 58M 3.82%
Dec 2023 1.59B 546M 34.17%
Mar 2024 1.62B 201M 12.39%
Organon & Co. (NYSE:OGN): Analyst Estimates
Mar 2024 1.62B 201M 12.39%
Sep 2025 1.52B 268.13M 17.58%
Oct 2025 1.55B 271.28M 17.42%
Dec 2025 1.59B 269.29M 16.84%
  • Analysts Price target

  • Financials & Ratios estimates

7.43%
Yield TTM
Organon & Co. (NYSE:OGN): Payout ratio
Payout ratio 22.75%
Organon & Co. (NYSE:OGN): Dividend Yield
2019
2020
2021 1.88%
2022 4.09%
2023 7.99%
Organon & Co. (NYSE:OGN): Debt to assets
Jun 2023 10979000000 11.53B 105.06%
Sep 2023 11012000000 11.60B 105.35%
Dec 2023 12058000000 12.12B 100.58%
Mar 2024 11891000000 11.84B 99.6%
Organon & Co. (NYSE:OGN): Cash Flow
Jun 2023 27M -70M -88M
Sep 2023 261M -55M -78M
Dec 2023 397M -81M -77M
Mar 2024 76M -96M -74M

Organon & alternative data

Areas of Focus

Organon & Co. (NYSE:OGN): Google Trends - Areas of Focus
19 Feb 2023 1931
26 Feb 2023 3331
5 Mar 2023 2636
12 Mar 2023 3034
19 Mar 2023 3429
26 Mar 2023 3432
2 Apr 2023 3243
9 Apr 2023 2828
16 Apr 2023 2435
23 Apr 2023 2740
30 Apr 2023 2946
7 May 2023 2229
14 May 2023 3338
21 May 2023 2830
28 May 2023 2036
4 Jun 2023 2435
11 Jun 2023 2531
18 Jun 2023 2030
25 Jun 2023 1215
2 Jul 2023 1917

Organon Biosimilars Products

Organon & Co. (NYSE:OGN): Google Trends - Organon Biosimilars Products
19 Feb 2023 27420
26 Feb 2023 8550
5 Mar 2023 16500
12 Mar 2023 12710
19 Mar 2023 16610
26 Mar 2023 12500
2 Apr 2023 0350
9 Apr 2023 15600
16 Apr 2023 85327
23 Apr 2023 46530
30 Apr 2023 0770
7 May 2023 11450
14 May 2023 0498
21 May 2023 17490
28 May 2023 12550
4 Jun 2023 136218
11 Jun 2023 20529
18 Jun 2023 0400
25 Jun 2023 252425
2 Jul 2023 0620

Organon Oncology Products

Organon & Co. (NYSE:OGN): Google Trends - Organon Oncology Products
12 Feb 2023 320
19 Feb 2023 00
26 Feb 2023 00
5 Mar 2023 020
12 Mar 2023 015
19 Mar 2023 190
26 Mar 2023 00
2 Apr 2023 00
9 Apr 2023 00
16 Apr 2023 00
23 Apr 2023 00
30 Apr 2023 00
7 May 2023 022
14 May 2023 00
21 May 2023 1616
28 May 2023 00
4 Jun 2023 140
11 Jun 2023 190
18 Jun 2023 035
25 Jun 2023 420

Organon Women's Health Products

Organon & Co. (NYSE:OGN): Google Trends - Organon Women's Health Products
26 Feb 2023 560
5 Mar 2023 530
12 Mar 2023 470
19 Mar 2023 520
26 Mar 2023 460
2 Apr 2023 510
9 Apr 2023 520
16 Apr 2023 460
23 Apr 2023 470
30 Apr 2023 500
7 May 2023 560
14 May 2023 460
21 May 2023 500
28 May 2023 480
4 Jun 2023 570
11 Jun 2023 530
18 Jun 2023 560
25 Jun 2023 450
2 Jul 2023 420
9 Jul 2023 410

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

Organon & Co. (NYSE:OGN): Job openings
Sep 2023 146
Oct 2023 119
Nov 2023 117
Dec 2023 154
Jan 2025 163
Feb 2025 102
May 2025 148
Jul 2025 170
Organon & Co. (NYSE:OGN): Employee count
Sep 2023 10,000
Oct 2023 10,000
Nov 2023 10,000
Dec 2023 10,000
Jan 2024 10,000
Feb 2024 10,000
Mar 2024 10,000
Apr 2024 10,000
May 2024 10,000
Jun 2024 10,000
Jul 2024 10,000

Organon & other data

75.50% +1.44%
of OGN is owned by hedge funds
192.56M +4.30M
shares is hold by hedge funds

Organon & Co. (NYSE:OGN): Insider trades (number of shares)
Period Buy Sel
Feb 2024 2720 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
MORRISSEY JOSEPH T. JR. officer: Head of Manufacturing
Common Stock 3,604 N/A N/A
Option
MORRISSEY JOSEPH T. JR. officer: Head of Manufacturing
Restricted Stock Units 3,604 N/A N/A
Option
NISITA VITTORIO officer: Head of Global Busines..
Common Stock 2,078 N/A N/A
Option
NISITA VITTORIO officer: Head of Global Busines..
Restricted Stock Units 2,078 N/A N/A
Option
FIEDLER SUSANNE officer: Chief Commercial Officer
Common Stock 4,989 N/A N/A
Option
FIEDLER SUSANNE officer: Chief Commercial Officer
Restricted Stock Units 4,989 N/A N/A
Option
WEAVER KIRKE officer: Gen. Counsel & Corp. S..
Common Stock 1,248 N/A N/A
Option
ALI KEVIN director, officer: Chief Execut..
Common Stock 22,161 N/A N/A
Option
ALI KEVIN director, officer: Chief Execut..
Restricted Stock Units 22,161 N/A N/A
Option
WALSH MATTHEW M officer: Chief Financial Officer
Common Stock 8,310 N/A N/A
Friday, 27 December 2024
zacks.com
Friday, 20 December 2024
zacks.com
Thursday, 19 December 2024
businesswire.com
Tuesday, 17 December 2024
https://thefly.com
Tuesday, 10 December 2024
youtube.com
Monday, 9 December 2024
zacks.com
Tuesday, 26 November 2024
zacks.com
Friday, 15 November 2024
zacks.com
Thursday, 14 November 2024
seekingalpha.com
Wednesday, 13 November 2024
seekingalpha.com
Monday, 4 November 2024
zacks.com
Thursday, 31 October 2024
seekingalpha.com
zacks.com
zacks.com
businesswire.com
Monday, 28 October 2024
zacks.com
businesswire.com
Thursday, 24 October 2024
zacks.com
fool.com
Monday, 21 October 2024
kiplinger.com
zacks.com
Monday, 14 October 2024
zacks.com
Wednesday, 9 October 2024
zacks.com
businesswire.com
Tuesday, 8 October 2024
zacks.com
zacks.com
Wednesday, 2 October 2024
zacks.com
youtube.com
Thursday, 26 September 2024
zacks.com
Wednesday, 25 September 2024
zacks.com
  • What's the price of Organon & stock today?

    One share of Organon & stock can currently be purchased for approximately $9.28.

  • When is Organon &'s next earnings date?

    Unfortunately, Organon &'s (OGN) next earnings date is currently unknown.

  • Does Organon & pay dividends?

    Yes, Organon & pays dividends and its trailing 12-month yield is 7.44% with 23% payout ratio. The last Organon & stock dividend of $0.28 was paid on 16 Dec 2021.

  • How much money does Organon & make?

    Organon & has a market capitalization of 3.71B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.44% to 6.26B US dollars.

  • What is Organon &'s stock symbol?

    Organon & Co. is traded on the NYSE under the ticker symbol "OGN".

  • What is Organon &'s primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - General industry.

  • How do i buy shares of Organon &?

    Shares of Organon & can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Organon & have?

    As Jul 2024, Organon & employs 10,000 workers.

  • When Organon & went public?

    Organon & Co. is publicly traded company for more then 4 years since IPO on 14 May 2021.

  • What is Organon &'s official website?

    The official website for Organon & is organon.com.

  • Where are Organon &'s headquarters?

    Organon & is headquartered at 30 Hudson Street, Jersey City, NJ.

  • How can i contact Organon &?

    Organon &'s mailing address is 30 Hudson Street, Jersey City, NJ and company can be reached via phone at +55 14306000.

Organon & company profile:

Organon & Co.

organon.com
Exchange:

NYSE

Full time employees:

10,000

Industry:

Drug Manufacturers - General

Sector:

Healthcare

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.

30 Hudson Street
Jersey City, NJ 07302

CIK: 0001821825
ISIN: US68622V1061
CUSIP: 68622V106